Recently, Alamri et al. (2018) showed that allosteric the AKT inhibitor MK2206 can inhibit the growth of mucoepidermoid carcinoma (MEC) cells in 2-D and 3-D CR cultures [99]. This evidence concerns the gene AKT1 and mucoepidermoid carcinoma.